| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 11/23/2000 | WO2000070021A2 Differentiated human embryoid cells and a method for producing them |
| 11/23/2000 | WO2000070020A1 Bacteria strain lactobacillus acidophilus n.v. ep 317/402 «narine» aaa used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof |
| 11/23/2000 | WO2000069913A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
| 11/23/2000 | WO2000069911A1 Long lasting insulinotropic peptides |
| 11/23/2000 | WO2000069862A2 Hemisynthetic method and intermediates thereof |
| 11/23/2000 | WO2000069455A2 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 11/23/2000 | WO2000069449A2 Conditioned cell culture medium compositions and methods of use |
| 11/23/2000 | WO2000069448A1 Bone marrow transplantation for treatment of stroke |
| 11/23/2000 | WO2000069441A1 Compositions and uses of et743 for treating cancer |
| 11/23/2000 | WO2000069269A1 Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium |
| 11/23/2000 | WO2000069268A1 Production of human cells, tissues, and organs in animals |
| 11/23/2000 | WO2000069257A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 11/23/2000 | WO2000040615A3 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
| 11/23/2000 | WO2000036090A3 Human brain endothelial cells and growth medium and method for expansion of primitive cd34+cd38- bone marrow stem cells |
| 11/23/2000 | WO2000023100A3 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 11/23/2000 | WO2000023053A3 Artificial antigen-specific cells and related methods |
| 11/23/2000 | WO2000009666A3 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 11/23/2000 | WO1999048482A3 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
| 11/23/2000 | DE19923027A1 Verfahren zur Inaktivierung von Viren A method of inactivating viruses |
| 11/23/2000 | CA2501421A1 Long lasting exendin-4 |
| 11/23/2000 | CA2373824A1 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 11/23/2000 | CA2373486A1 Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium |
| 11/23/2000 | CA2373191A1 Full-length molecules expressed in human tissues |
| 11/23/2000 | CA2372534A1 Differentiated human embryoid cells and a method for producing them |
| 11/23/2000 | CA2372119A1 Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily |
| 11/23/2000 | CA2371212A1 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 11/23/2000 | CA2369085A1 Ex vivo expansion of mammalian hematopoietic stem cells |
| 11/23/2000 | CA2368620A1 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 11/22/2000 | EP1054064A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35 |
| 11/22/2000 | EP1053754A1 Method of inactivating viruses |
| 11/22/2000 | EP1053343A2 Targeting of genetic vaccine vectors |
| 11/22/2000 | EP1053341A1 Use of negative regulation elements for nerve-specific expression of transgenes |
| 11/22/2000 | EP1053312A2 Optimization of immunomodulatory properties of genetic vaccines |
| 11/22/2000 | EP1053302A2 Expanded and genetically modified populations of human hematopoietic stem cells |
| 11/22/2000 | EP1053301A1 A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use |
| 11/22/2000 | EP1053025A2 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery |
| 11/22/2000 | EP1053009A2 Use of heregulin as an epithelial cell growth factor |
| 11/22/2000 | EP1053006A1 Costimulatory blockade and mixed chimerism in transplantation |
| 11/22/2000 | EP1053002A1 Treatment of bony defects with osteoblast precursor cells |
| 11/22/2000 | EP1052988A1 Methods and compositions for inactivating viruses |
| 11/22/2000 | EP0703988B1 Mesothelial cell gene therapy |
| 11/22/2000 | EP0604631B1 Use of envelopes of bacteria of the order of Beggiatoales or of the genus Vitreoscilla as an active ingredient of a medicament for stimulating non-specific immunity |
| 11/22/2000 | CN1274260A Hypersensitive response elicitor from i(Erwinia Amylovora) and its use |
| 11/22/2000 | CN1273859A Buccal lozenge for activating intelligent genes and increasing intelligence quotient |
| 11/22/2000 | CN1273851A Chinese medicine for treating intraocular hemorrhage |
| 11/22/2000 | CN1273845A 胃炎胶囊 Gastritis Capsules |
| 11/22/2000 | CN1273838A Nutritive composition containing symbiotic fermentation culture medium of dead probiotics |
| 11/22/2000 | CN1273837A Black ointment |
| 11/22/2000 | CN1273835A Chinese medicine for treating rheumatism |
| 11/22/2000 | CN1273834A Chinese medicine for treating rheumatism |
| 11/22/2000 | CN1273816A Activated and concentrated liquid containing minerals and race elements and preparing process thereof |
| 11/22/2000 | CN1273794A Lushenwuxiang chicken and its cooking method |
| 11/22/2000 | CN1273786A Process for preparing bee larva products |
| 11/22/2000 | CN1273785A Process for preparing freeze-dried royal jelly tablets |
| 11/22/2000 | CN1273780A Health-care milk |
| 11/22/2000 | CN1058636C Medicine for preventing liver cancer |
| 11/22/2000 | CN1058631C 银屑病胶囊 Psoriasis capsules |
| 11/22/2000 | CN1058630C Chinese drugs for curing male sexual dys-function and its preparing tech. |
| 11/22/2000 | CN1058629C 'Longteng' medicinal wine |
| 11/22/2000 | CN1058624C Burns curing powder and its prepn. method |
| 11/22/2000 | CN1058623C Anti-hepatitis B capsule |
| 11/22/2000 | CN1058621C External-use ointment for treating bone tuberculosis |
| 11/22/2000 | CN1058620C External-use Chinese patent drug for treating cancer, and its prodn. tech. |
| 11/22/2000 | CN1058613C Ointment for resolving blood stasis and prepn. method |
| 11/22/2000 | CN1058611C Antidiarrheal Chinese medicine |
| 11/22/2000 | CN1058610C Immunologic facilitation agent for inhibiting growth of tumor |
| 11/21/2000 | US6150505 Preparing aqueous solution of fibrinogen, thrombin and factor xiii, before coagulation adding an oil heated to 50-80 degrees celsius to form emulsion, mixing until crosslinked microbeads are formed, isolating beads; glutaraldehyde-free |
| 11/21/2000 | US6150340 RNA-dependent amidotransferase from Staphylococcus aureus |
| 11/21/2000 | US6150338 Delivery and expression of a recombinant vector containing a dna sequence encoding a protein involved in the regulation of smooth muscle tone into a smooth muscle cell |
| 11/21/2000 | US6150326 Means for treating autoimmune diseases and method for the treatment thereof |
| 11/21/2000 | US6150125 Flea protease proteins and uses thereof |
| 11/21/2000 | US6150109 Lipophilic quenching of viral inactivating agents |
| 11/21/2000 | US6149946 Method and product using sturgeon notochord for alleviating the symptoms of arthritis |
| 11/21/2000 | US6149917 Culturing, inoculating the cells with japanese encephalitis virus, propagating and multiplying the virus, harvesting, purifying viruses by ion-exchange chromatographic process, adsorption chromatography and gel permeation |
| 11/21/2000 | US6149907 Treatments using sertoli cells |
| 11/21/2000 | US6149906 Activation of t-lymphocytes and induction of antigen-specific immune responses; preventing, treating various diseases ( viral, bacterial, fungal), botulism toxin, poison ivy, poison sumac |
| 11/21/2000 | US6149902 Manipulation of non-terminally differentiated cells using the notch pathway |
| 11/21/2000 | US6149796 Electrolyzing tissue in aqueous solution thereby dissolving and separating tissue components in the vicinity of anode, said tissue filled in an anode vessel, crystallizing, filtering residue |
| 11/21/2000 | US6149671 Laser/sensitizer assisted immunotherapy |
| 11/21/2000 | CA1341142C Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
| 11/16/2000 | WO2000068399A2 Vector-mediated delivery of integrating transposon sequences |
| 11/16/2000 | WO2000068386A1 Autotaxin variants and uses to treat diseases of metabolism |
| 11/16/2000 | WO2000068384A2 NOVEL NUCLEIC ACIDS AND PROTEINS WITH p53 ACTIVITY AND ALTERED TETRAMERIZATION DOMAINS |
| 11/16/2000 | WO2000068380A2 Extracellular matrix and adhesion-associated proteins |
| 11/16/2000 | WO2000068379A1 Methods for treating tumors using antiangiogenic compounds |
| 11/16/2000 | WO2000068261A2 Attenuated microorganisms for the treatment of infection |
| 11/16/2000 | WO2000068258A2 Compounds exhibiting an antibiotic activity |
| 11/16/2000 | WO2000067785A2 Staphyloccocus aureus antigen-containing whole cell vaccine |
| 11/16/2000 | WO2000067774A2 Materials for soft tissue augmentation and methods of making and using same |
| 11/16/2000 | WO2000067766A1 Restorative and regenerative preparation, method for producing the same and therapeutical use according to l.v. dubinina |
| 11/16/2000 | WO2000067765A1 Composition containing dried roe and yohimbine for treating impotence in men |
| 11/16/2000 | WO2000067764A2 Improved method for treating mammals with modified mammalian blood |
| 11/16/2000 | WO2000067761A1 Compositions and methods for identifying antigens which elicit an immune response |
| 11/16/2000 | WO2000067696A2 Lactic acid bacteria with anxiolytic properties and uses thereof |
| 11/16/2000 | WO2000054728A3 Use of a bacterial composition for treating periodontal diseases |
| 11/16/2000 | WO2000053633A3 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases |
| 11/16/2000 | WO2000047223A3 Viral vaccine |
| 11/16/2000 | WO2000044389A3 Method for preparing membrane vesicles |
| 11/16/2000 | WO2000042179A3 Complex-forming proteins |
| 11/16/2000 | WO2000042168A3 Bifidobacterium in the treatment of inflammatory disease |